US regulator to rule on pain drug Vioxx. FDA has been asked to decide if the benefits to patients justify the increased risks. The painkillers - called COX-2 inhibitors - are sold under brand names such as Celebrex. Merck said it would consider selling it if it gets FDA approval for the drug. The move caused the firm's fourth-quarter earnings to slide to $1.1bn (Â£581m)